Unlock instant, AI-driven research and patent intelligence for your innovation.

Anticancer compounds

A technology of compounds and drugs, applied in the field of anticancer compounds

Active Publication Date: 2020-01-03
PHARMA MAR U
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the PKS systems of penicillin and onamide have been described, it has not been possible to obtain these compounds through biotechnological methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anticancer compounds
  • Anticancer compounds
  • Anticancer compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0204] Example 1: Bacteria Isolation

[0205] The penicillin-producing bacterium Labrenzia PHM005 was isolated in 2005 from a sediment sample collected at a depth of 18 m from a highly epiphytic and unidentified coral sponge habitat off the coast of Kenya. Approximately 5 grams of marine gravel material was collected in 50 ml Falcon tubes containing sterile artificial sea water (ASW) and kept at 5°C for 5 days before processing. Once in the laboratory, samples were homogenized and 100 μl of 1:100 diluted ASW was spread directly onto Petri dishes with 27 g / L sea salt (Tropic PRO-REEF), 16g / L agar and 0.2mg / mL cycloheximide sea salt medium. After three weeks of incubation at 28°C, brownish colonies were picked and transferred to the same sea salt medium to confirm purity and produce biomass for molecular characterization, one colony was inoculated in liquid marine broth , for further storage in 20% glycerol at -80°C as a cell bank.

Embodiment 2

[0206] Example 2: Electron Microscopy.

[0207] Cells in mid-exponential growth phase were adsorbed on 400 mesh carbon-collodion-coated grids for 2 min, negatively stained with 2% uranyl acetate, imaged with a Jeol JEM 1011 transmission electron microscope operated at 100 kV and analyzed with CCDGatan Erlangshen ES1000W camera shooting.

Embodiment 3

[0208] Example 3: 16S rRNA Characterization.

[0209] For DNA extraction, strains were grown in marine liquid medium (DIFCO 1196) for 72 hours. Cells were recovered and lysed by boiling with 4% NP40 for 10 minutes. Cell debris was discarded by centrifugation. The 16S rDNA gene was amplified by polymerase chain reaction using bacterial primers F1 and R5. Using BioNumerics V7.5 (Applied Maths), a phylogenetic tree was generated by performing cluster analysis based on the similarity coefficient and UPGMA of pairwise alignments ( figure 2 ). Phylogenetic neighbors were identified by comparison with the SILVA LTPs123 database, and pairwise 16S rDNA gene sequence similarities were calculated.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Anticancer compounds of general formula (I), wherein R1 to R4 take various meanings, for use in the treatment of cancer. A novel Labrenziasp. strain named PHM005 with Accession Deposit Number CECT-9225, a method of producing compounds of the invention and analogues thereof by using the PHM005 strain and the Lab gene cluster codifying the biosynthesis of pederin-like and onnamide-like compounds arealso provided.

Description

technical field [0001] The present invention relates to the direct or indirect production of anticancer compounds from bacteria, and to novel anticancer compounds, pharmaceutical compositions containing them and their use as anticancer agents. Background technique [0002] In 1949, Ueta reported the isolation of toxic components from the beetle Paederus fuscipes (Kyushu Igaku Zasshi, 1949, 249). Four years later, Pavan and Bo also described substances from the same beetle species with the same physical properties (Physiol. Comp. Oecol. 1953, 3, 307). The structure of this toxic compound called pederin was first proposed by Cadani and colleagues in 1965 (Tetrahedron Lett. 1965, 2537), but in 1968 by Furusaki and colleagues based on the crystal structure of the derivative A correction was made. (Tetrahedron Lett. 1968, 6301). The structure of cyanidin is: [0003] [0004] In addition, Cardani's research group reported the isolation of two additional compounds, called p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D407/12A61K31/351A61P35/00
CPCC07D407/12A61P35/00C12P17/06C12N1/205C12R2001/07C12R2001/19C12R2001/38C12R2001/465A61K31/351C12R2001/01
Inventor 利布拉达·玛丽亚·卡涅多赫南德斯费尔南多·德拉卡列韦尔杜玛丽亚·皮拉尔·罗德里格斯拉莫斯玛丽亚·德尔·卡门·施勒伊斯纳桑切斯帕兹·苏尼加吉龙
Owner PHARMA MAR U